The GLS enzyme is reported to have a positive correlation with cancerous tumor growth from normal cells due to enhanced glutaminolysis (Lora et al., 2004; Xiang et al., 2015), making it is a potential target for effective cancer therapeutic. The gene discussed is GLS; the disease is cancer.